AKYA
|
$3.81
-1.04%
-1.05%
170K
|
Professional, Scientific, and T...
(0.0% 1d)
(-23.8% 1m)
(-47.9% 1y)
(0.0% 2d)
(0.0% 3d)
(-5.2% 7d)
(-44.49%
volume)
Earnings Calendar: 2024-03-04
Market Cap: $ 187,226,185
https://www.akoyabio.com
Sec
Filling
|
Patents
| n/a employees
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.
t-cell
treatment
ceiling
add to watch list
Paper trade
email alert is off